Cutler Group LP Arcturus Therapeutics Holdings Inc. Put Options Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$13.05 - $22.13 $101,790 - $172,614	-7,800 Reduced 97.5%	200 $3,000
Q2 2022 Aug 04, 2022	SELL	$12.26 - $31.17 $79,690 - $202,605	-6,500 Reduced 44.83%	8,000 $92,000
Q1 2022 Apr 14, 2022	BUY	$17.64 - $39.57 $169,344 - $379,872	9,600 Added 195.92%	14,500 $116,000
Q4 2021 Jan 18, 2022	BUY	$34.2 - $47.56 $112,860 - $156,948	3,300 Added 206.25%	4,900 $45,000
Q3 2021 Oct 26, 2021	SELL	$27.88 - $58.25 $11,152 - $23,300	-400 Reduced 20.0%	1,600 $5,000
Q2 2021 Jul 19, 2021	SELL	$25.79 - $42.11 $25,790 - $42,110	-1,000 Reduced 33.33%	2,000 $36,000
Q1 2021 Apr 26, 2021	SELL	$38.75 - $86.92 $623,875 - $1.4 Million	-16,100 Reduced 84.29%	3,000 $64,000
Q4 2020 Jan 21, 2021	SELL	$34.61 - $123.66 $124,596 - $445,176	-3,600 Reduced 15.86%	19,100 $375,000
Q3 2020 Oct 27, 2020	SELL	$37.49 - $63.19 $93,725 - $157,975	-2,500 Reduced 9.92%	22,700 $121,000
Q2 2020 Jul 22, 2020	BUY	$12.66 - $58.27 $305,106 - $1.4 Million	24,100 Added 2190.91%	25,200 $135,000
Q1 2020 May 07, 2020	BUY	$9.31 - $18.26 $931 - $1,826	100 Added 10.0%	1,100 $7,000
Q4 2019 Feb 06, 2020	BUY	$8.93 - $12.41 $8,930 - $12,410	1,000 New	1,000 $0

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.